Fmoc-Lys(Mmt)-OH is a protected lysine derivative used in solid-phase peptide synthesis. Its Fmoc group enables temporary protection of the alpha-amino group during peptide assembly, while the Mmt group protects the lysine side chain.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Fmoc-Lys(Mmt)-OH?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
N2-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-lysine hydrochloride
pharmaceutical intermediate
N-Fmoc-7-methyl-L-tryptophan
pharmaceutical intermediate
(R)-1-Fmoc-piperidine-3-carboxylic acid
pharmaceutical intermediate
4-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)oxane-4-carboxylic acid
pharmaceutical intermediate
(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-(carbamoylamino)-N-[4-(hydroxymethyl)phenyl]pentanamide
pharmaceutical intermediate
N-[6-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-N-[4-(hydroxymethyl)phenyl]-L-ornithinamide
pharmaceutical intermediate
(S)-2-((S)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-3-METHYLBUTANAMIDO)-5-UREIDOPENTANOIC ACID
pharmaceutical intermediate
Dxd
pharmaceutical intermediate
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[[(4-methoxyphenyl)-diphenylmethyl]amino]hexanoic acid
CTYHQVFFQRDJSN-LHEWISCISA-N
COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)NCCCC[C@@H](C(=O)O)NC(=O)OCC4C5=CC=CC=C5C6=CC=CC=C46
Sourcing Fmoc-Lys(Mmt)-OH?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.